Recombinant Proteins
- (286)
- (11)
- (65,895)
- (1)
- (2)
- (970)
- (1)
- (23,542)
- (5)
- (1)
- (1)
- (67)
- (218)
- (4,423)
- (23)
- (1)
- (4)
- (2)
- (13)
- (21,453)
- (3)
- (4)
- (3)
- (1)
- (2)
- (4)
- (14)
- (71)
- (2)
- (2)
- (2)
- (1)
- (3)
- (2)
- (1)
- (157)
- (3)
- (4)
- (1)
- (1)
- (1)
- (3)
- (253)
- (22,601)
- (1)
- (1)
- (2)
- (1)
- (13)
- (26,805)
- (255)
- (32)
- (3)
- (708)
- (14)
- (2)
- (1)
- (8)
- (1)
- (5)
- (1)
- (105)
- (1)
- (3,765)
- (1,407)
- (3)
- (4)
- (5)
- (1)
- (1)
- (1)
- (1)
- (14)
- (138)
- (48)
- (6)
- (17)
- (2)
- (1)
- (10)
- (4)
- (81)
- (12)
- (2)
- (3)
- (80)
- (4)
- (113)
- (96)
- (19)
- (1)
- (1)
- (4)
- (1)
- (1,523)
- (2)
- (1)
- (160)
- (18)
- (48)
- (3)
- (3)
- (1)
- (2)
- (9)
- (27)
- (2)
- (204)
- (1)
- (4)
- (1)
- (2)
- (114)
- (44)
- (2)
- (1)
- (1)
- (4)
- (1)
- (1)
- (3)
- (1)
- (23,710)
- (6)
- (3)
- (1)
- (1)
- (63)
- (6)
- (2)
- (7)
- (5)
- (1)
- (2)
- (1)
- (1)
- (6,758)
- (6)
- (4)
- (1)
- (3)
- (1)
- (3)
- (2)
- (13)
- (17)
- (1)
- (3)
- (3)
- (4)
- (27,101)
- (240)
- (1)
- (3)
- (2)
- (1)
- (2)
- (1)
- (89)
- (559)
- (96)
- (2)
- (1)
- (1)
- (2)
- (1)
- (27)
- (1)
- (8)
- (15)
- (1)
- (72)
- (1)
- (1,303)
- (1)
- (3)
- (16)
- (1)
- (3)
- (1)
- (1)
- (1)
- (8)
- (1)
- (4)
- (1)
- (1)
- (29,094)
- (5)
- (22)
- (8)
- (4)
- (1,291)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (8)
- (14)
- (32)
- (24)
- (1)
- (2)
- (16)
- (233)
- (9)
- (2)
- (5)
- (1)
- (2)
- (2)
- (2)
- (23)
- (5)
- (3)
- (3)
- (2)
- (14)
- (23,574)
- (1)
- (48)
- (15)
- (1)
- (2)
- (45,210)
- (5,673)
- (245)
- (168)
- (56)
- (3,363)
- (7)
- (1)
- (3)
- (18)
- (2)
- (62)
- (1)
- (4)
- (2)
- (9)
- (59)
- (1)
- (2)
- (3)
- (1)
- (391)
- (1)
- (3)
- (2)
- (1)
- (1)
- (1)
- (3)
- (2)
- (3)
- (19)
- (7)
- (2)
- (2)
- (3)
- (45)
- (1)
- (1)
- (1)
- (2)
- (5)
- (1)
- (1)
- (1)
- (2)
- (8)
- (2)
- (3)
- (43,112)
- (1)
- (11)
Filtered Search Results
R&D Systems™ Recombinant Human IL-13 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Conjugate | Unconjugated |
|---|---|
| Molecular Weight (g/mol) | 12.3 kDa |
| Gene ID (Entrez) | 3596 |
Invitrogen™ Ovalbumin, Texas Red™ Conjugate
Labeled with bright, photostable and pH-insensitive Alexa Fluor 594 dye
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Gibco™ Human CNTF Recombinant Protein
Recombinant Protein
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Purity or Quality Grade | ≥98% by SDS-PAGE and HPLC |
|---|---|
| Conjugate | Unconjugated |
| pH Range | 7.5 |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 22.7 kDa |
| Common Name | CNTF |
| Gene Symbol | CNTF |
| Activity | ED50 = 50 - 150 ng/mL; determined by the dose-dependent proliferation of human TF-1 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Storage Requirements | -20°C |
| Sequence | Human CNTF recombinant protein contains 199 amino acids |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human CNTF |
| Accession Number | P26441 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | AI429687; Ciliary neurotrophic factor; ciliary neurotropic factor; Cntf; HCNTF; H-CNTF |
| Product Type | Protein |
| Gene ID (Entrez) | 1270 |
| Formulation | 5mM sodium phosphate with 75mM NaCl and no preservative; pH 7.5 |
| Recombinant | Recombinant |
R&D Systems™ Recombinant Human TNF-alpha Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Mouse TNF-alpha (aa 80-235) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Invitrogen™ SARS-CoV-2 Nucleocapsid (aa1-419), His Tag Recombinant Protein
Recombinant Protein
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Regulatory Status | RUO |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE; >95% by HPLC |
| Conjugate | Unconjugated |
| Form | Liquid |
| Molecular Weight (g/mol) | 49.4 kDa |
| Formulation | 20 mM tris with 0.1 mM EDTA, 10% glycerol, 500 mM NaCl and no preservative; pH 8.0 |
| Endotoxin Concentration | <1.0 EU/μg |
| Sequence | SARS-CoV-2 Nucleocapsid, Met1-Ala419 with an N-terminal His-tag |
| Concentration | 0.56 mg/mL |
| For Use With (Application) | Control,ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | SARS-CoV-2 Nucleocapsid (aa1-419), His Tag |
| Recombinant | Recombinant |
| Purity or Quality Grade | >95% by SDS-PAGE; >95% by HPLC |
|---|---|
| Conjugate | Unconjugated |
| pH Range | 7.4 |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 25.9 kDa |
| Common Name | SARS-CoV-2 Spike Protein RBD |
| Activity | 1.Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV-2 Spike RBD (Catalog: RP01258) at 2 μg/mL (100 μL/well) can bind Human ACE-2 (Catalog: RP01275) with a linear range of 0.001-2.96 ng/mL. 2.Immobilized human ACE2 on COOH Chip, can bind SARS-COV-2 Spike RBD Protein with an affinity constant of 35.3 nM as determined in a SPR assay (Nicoya OpenSPR). 3.Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV-2 Spike RBD (Catalog: RP01258) at 2 μg/mL (100 μL/well) can bind Human ACE-2 (Catalog: RP01275) with a linear range of 0.001-1.69 ng/mL. |
| Endotoxin Concentration | <1.0 EU/μg |
| Storage Requirements | -20°C or -80°C if preferred |
| Sequence | SARS-CoV-2 Spike Protein RBD, amino acids Arg319-Phe541 (Accession # YP_009724390.1) (s-RBD region) with a C-terminal His-tag |
| Expression System | HEK293 cells |
| For Use With (Application) | Control,ELISA Standard,Binding Assay,Surface Plasmon Resonance,Western Blot |
| Name | SARS-CoV-2 Spike Protein (RBD) (aa319-541), His Tag |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV2; SARS-CoV-2 |
| Product Type | Protein |
| Formulation | PBS with no preservative; pH 7.4 |
| Protein Tag | His-tag |
| Recombinant | Recombinant |
R&D Systems™ Recombinant Human R-Spondin 1 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Human R-Spondin 1 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Human BDNF Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Buffer | Lyophilized from a 0.2 μm filtered solution in Sodium Citrate and NaCl. |
|---|---|
| Purity or Quality Grade | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining. |
| Conjugate | Unconjugated |
| Specific Reactivity | BDNF |
| Molecular Weight (g/mol) | observed_molecular_weight: 13-14 kDa, under reducing conditions. |
| Endotoxin Concentration | <0.10 EU per 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Source | Spodoptera frugiperda,Sf 21 (baculovirus)-derived BDNF protein His129-Arg247 Accession &Num; P23560 100% sequence homology with Mouse,Rat,Canine,Equine and all other mammalian proteins examined. |
| Accession Number | P23560 |
| Regulatory Status | RUO |
| Gene ID (Entrez) | 627 |
| Reconstitution | Reconstitute at 250 μg/mL in water. |
| Species | Human,Mouse,Rat,Canine,Equine |
| Recombinant | Recombinant |
R&D Systems™ Recombinant Human TfR Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Human IL-18/IL-1F4 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining |
|---|---|
| Conjugate | Unconjugated |
| Common Name | IL-18/IL-1F4 |
| Molecular Weight (g/mol) | Predicted MW: 18kDa Observed MW: 18kDa, reducing conditions |
| Gene Symbol | IL18 |
| Endotoxin Concentration | <0.10 EU per 1μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Expression System | E. coli-derived Tyr37-Asp193 |
| For Use With (Application) | Bioactivity |
| Source | E. coli-derived human IL-18/IL-1F4 protein Tyr37-Asp193 |
| Accession Number | Q14116 |
| Gene Alias | Iboctadekin, IFN-gamma-inducing factor, IGIF, IGIFIL-1 gamma, IL18, IL-18MGC12320, IL-1F4, IL1F4iboctadekin, IL-1g, Interferon gamma-inducing factor, interleukin 18 (interferon-gamma-inducing factor), Interleukin-1 gamma, interleukin-18 |
| Biological Activity | Measured by its ability to induce IFN-gamma secretion by KG-1 human acute myelogenous leukemia cells in the presence of TNF-alpha . The ED50 for this effect is typically 1.5-9ng/mL. |
| Gene ID (Entrez) | 3606 |
| Species | Human |
| Recombinant | Recombinant |
R&D Systems™ Recombinant Human/Mouse Wnt-5a Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | 80%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 38 kDa |
| Gene ID (Entrez) | 7474 |
| Quantity | 10 μg |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Source | Chinese Hamster Ovary cell line,CHO-derived Wnt-5a protein Gln38-Lys380 |
| Recombinant | Recombinant |
| Name | Wnt-5a |
| Regulatory Status | RUO |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 14.6 kDa |
| Formulation | protein with no preservative |
| Sequence | Human GM-CSF recombinant protein contains 128 amino acids |
| For Use With (Application) | ELISA,Immunoprecipitation,Western Blot |
| Source | E. Coli |
| Name | Human GM-CSF |
| Recombinant | Recombinant |
Gibco™ Mouse FGF-basic (FGF-2/bFGF) Recombinant Protein
Recombinant Protein
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | FGF2 |
| Molecular Weight (g/mol) | 17 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 = 0.1 - 1.0 ng/mL; determined by the dose-dependent proliferation of BALB/3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Mouse FGF-basic (FGF-2/bFGF) |
| Purification Method | Purified |
| Gene Alias | Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); Fibroblast growth factor basic; HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 = 0.1 - 1.0 ng/mL; determined by the dose-dependent proliferation of BALB/3T3 cells. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Neurobiology, Microbiology, Angiogenesis, Oncology |
| Species | Mouse |
| Recombinant | Recombinant |
| Shipping Condition | Wet Ice |
| Content And Storage | 4°C |
| Gene Symbol | FGF2 |
| Sequence | PALPEDGGAA FPPGHFKDPK RLYCKNGGFF LRIHPDGRVD GVREKSDPHV KLQLQAEERG VVSIKGVCAN RYLAMKEDGR LLASKCVTEE CFFFERLESN NYNTYRSRKY SSWYVALKRT GQYKLGSKTG PGQKAILFLP MSAKS |
| Storage Requirements | 4°C |
| Protein Subtype | FGFs (Fibroblast Growth Factors) |
| Accession Number | P15655 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 14173 |
| Product Line | Gibco |